Cell Proliferation: review time and acceptance speed
ISSN 0960-7722 · ISSN 1365-2184 · Wiley · Biochemistry, Genetics and Molecular Biology
Half of the articles Cell Proliferation accepted in 2025 were accepted within 92 days of submission (n = 138); the middle half took 67–135 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Cell Proliferation take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2025 | 138 | 67 | 92 | 135 | — | 0.0% | 100% |
| 2024 | 167 | 65 | 91 | 124 | — | 0.0% | 100% |
| 2023 | 165 | 49 | 67 | 101 | — | 0.6% | 96% |
| 2022 | 185 | 54 | 76 | 111 | — | 0.5% | 97% |
| 2021 | 160 | 52 | 76 | 101 | — | 0.6% | 96% |
| 2020 | 182 | 51 | 73 | 104 | — | 2.8% | 98% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Distribution in 2025
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 1 | 0.7% |
| 30–59 | 23 | 16.7% |
| 60–89 | 44 | 31.9% |
| 90–119 | 25 | 18.1% |
| 120–149 | 19 | 13.8% |
| 150–179 | 11 | 8.0% |
| 180–209 | 6 | 4.3% |
| 210–239 | 5 | 3.6% |
| 240–269 | 2 | 1.4% |
| 270–299 | 1 | 0.7% |
| 300–329 | 0 | 0.0% |
| 330–359 | 0 | 0.0% |
| 360+ | 1 | 0.7% |
From acceptance to online publication
After acceptance, half of the 2025 articles appeared online within 16 days (middle half 12–22 days, n = 138).
From submission to online publication, the median was 112 days (middle half 88–155 days, n = 138).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Open access (listed in DOAJ). Listed APC: $3,680 (DOAJ).
No institutional payments for this journal are recorded in OpenAPC.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | Yes (DOAJ record) |
|---|---|
| Articles indexed for MEDLINE in 2025 | Yes |
| Retractions | 0 retracted articles among 830 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 0.0% of 2025 articles |
| Publication volume | 142 articles added to PubMed in 2025 (-17% vs 2024). |
Topics and scope
- Mesenchymal stem cell research (10% of indexed topics)
- Cancer Cells and Metastasis (8% of indexed topics)
- Pluripotent Stem Cells Research (8% of indexed topics)
- MicroRNA in disease regulation (5% of indexed topics)
- Reproductive Biology and Fertility (5% of indexed topics)
- Cancer-related molecular mechanisms research (4% of indexed topics)
Biochemistry, Genetics and Molecular Biology journalsMedicine journalsMolecular Biology journals
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Cell Proliferation, 92 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Cell Biology International | 126 (2025, n = 129) | ≈$3,730 | — | No | Yes |
| Stem Cell Reviews and Reports | 61 (2025, n = 80) | ≈$4,390 | — | No | Yes |
| World Journal of Stem Cells | 111 (2025, n = 124) | — | — | No | No |
| Stem Cells International | 217 (2025, n = 96) | $2,830 | — | Yes | No |
| Stem Cells | 136 (2025, n = 77) | ≈$4,477 | — | No | Yes |
| Human Cell | 134 (2025, n = 160) | ≈$2,490 | — | No | Yes |
| Stem Cell Research & Therapy | 125 (2025, n = 727) | $3,290 | $3,043 (19 payments) | Yes | Yes |
| Stem Cells Translational Medicine | 168 (2025, n = 75) | $2,822 | — | Yes | Yes |
| Frontiers in Cell and Developmental Biology | 69 (2025, n = 1,074) | ≈$3,850 | $3,242 (124 payments) | Yes | No |
No journals match these filters.
Frequently asked questions
How long does Cell Proliferation take to accept a paper?
Half of the articles Cell Proliferation accepted in 2025 were accepted within 92 days of submission (n = 138); the middle half took 67–135 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Cell Proliferation articles published online?
Half of the articles accepted in 2025 appeared online within 16 days of acceptance (n = 138).
Does Cell Proliferation charge an article processing charge (APC)?
Listed APC: $3,680 (DOAJ).
Sources and method
Journal identity: ISSN-L 0960-7722; NLM ID 9105195; OpenAlex record. Speed figures use 138 articles accepted in 2025 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.